Anti-obesity potential of almond (Prunus dulcis) in experimental animals under cafeteria and atherogenic diets.

Almond Atherogenic diet CNS parameters Cafeteria diet Lipid parameters Obesity

Journal

Saudi journal of biological sciences
ISSN: 1319-562X
Titre abrégé: Saudi J Biol Sci
Pays: Saudi Arabia
ID NLM: 101543796

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 08 03 2021
revised: 06 04 2021
accepted: 07 04 2021
entrez: 5 7 2021
pubmed: 6 7 2021
medline: 6 7 2021
Statut: ppublish

Résumé

Natural dietary supplements are progressively getting famous to supplant synthetic substances particularly in chronic morbidities. The aim of this study was to evaluate the anti-obesity potential of almond on the normal, Cafeteria, and Atherogenic diets. Parameters such as change in body weight, body temperature, lipid profile, organ weights, and fat pad weights were assessed. Central Nervous System related studies (Despair Swim test and Elevated Plus maze test) were also performed to comprehend the effect of the diets, and almond on the brain. All of the experimental animals were randomly assigned to one of three diet categoriesregular, cafeteria, or atherogenic, and fed those diets for 40 days. Each diet had the control group, standard drug group and three almond groups (low dose: 50; medium dose: 100 and high dose: 200 mg/kg body weight). Body weight was recorded every alternate day. On 40th day, body temperature was measured. On day 41, lipid parameters, organ weights, fat pad weights and the CNS parameters were evaluated. ANOVA followed by Duncans Multiple Range Test were used for statistical analysis. Treatment of animals with either a low or high dose of almond as well as a standard herb prevented a rise in body weight significantly (p = 0.01) in all three diet groups. When a regular diet was replaced with a cafeteria and atherogenic diet, the serum levels of triglycerides and LDL increased significantly, while HDL levels decreased significantly. Overall, almond preparation reduced lipid parameters, organ weights, fat-pad weights, and stabilized CNS parameters substantially. The almond high dose was the most effective of all the almond preparations. Our study suggests that chronic administration of almond independently reduces the body weight in experimental animals.

Sections du résumé

BACKGROUND & OBJECTIVES OBJECTIVE
Natural dietary supplements are progressively getting famous to supplant synthetic substances particularly in chronic morbidities. The aim of this study was to evaluate the anti-obesity potential of almond on the normal, Cafeteria, and Atherogenic diets.
MATERIALS AND METHODS METHODS
Parameters such as change in body weight, body temperature, lipid profile, organ weights, and fat pad weights were assessed. Central Nervous System related studies (Despair Swim test and Elevated Plus maze test) were also performed to comprehend the effect of the diets, and almond on the brain. All of the experimental animals were randomly assigned to one of three diet categoriesregular, cafeteria, or atherogenic, and fed those diets for 40 days. Each diet had the control group, standard drug group and three almond groups (low dose: 50; medium dose: 100 and high dose: 200 mg/kg body weight). Body weight was recorded every alternate day. On 40th day, body temperature was measured. On day 41, lipid parameters, organ weights, fat pad weights and the CNS parameters were evaluated. ANOVA followed by Duncans Multiple Range Test were used for statistical analysis.
RESULTS RESULTS
Treatment of animals with either a low or high dose of almond as well as a standard herb prevented a rise in body weight significantly (p = 0.01) in all three diet groups. When a regular diet was replaced with a cafeteria and atherogenic diet, the serum levels of triglycerides and LDL increased significantly, while HDL levels decreased significantly. Overall, almond preparation reduced lipid parameters, organ weights, fat-pad weights, and stabilized CNS parameters substantially.
INTERPRETATION & CONCLUSION CONCLUSIONS
The almond high dose was the most effective of all the almond preparations. Our study suggests that chronic administration of almond independently reduces the body weight in experimental animals.

Identifiants

pubmed: 34220264
doi: 10.1016/j.sjbs.2021.04.024
pii: S1319-562X(21)00280-1
pmc: PMC8241617
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4062-4068

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Indian J Exp Biol. 2009 Mar;47(3):176-81
pubmed: 19405382
J Nutr. 2006 Dec;136(12):2987-92
pubmed: 17116708
Cell. 2001 Feb 23;104(4):531-43
pubmed: 11239410
Biol Psychiatry. 2003 Aug 1;54(3):330-7
pubmed: 12893108
Yakubutsu Seishin Kodo. 1992 Jun;12(3):105-11
pubmed: 1414030
Nutr Rev. 2011 Apr;69(4):171-85
pubmed: 21457263
Eur J Pharmacol. 1990 Mar 13;178(1):135-8
pubmed: 1970538
Int J Obes Relat Metab Disord. 1993 Jun;17(6):307-15
pubmed: 8392495
J Agric Food Chem. 2012 Jul 11;60(27):6694-702
pubmed: 22296169
Food Chem. 2010 Oct 1;122(3):819-825
pubmed: 25544797
Circulation. 2002 Sep 10;106(11):1327-32
pubmed: 12221048
J Nutr. 2008 May;138(5):908-13
pubmed: 18424600
Int J Obes. 1991 Jul;15(7):487-95
pubmed: 1894425
Appl Biochem Biotechnol. 2010 Sep;162(2):358-72
pubmed: 19672721
Am J Clin Nutr. 1999 Sep;70(3 Suppl):504S-511S
pubmed: 10479223
Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R288-97
pubmed: 15044180
Ann Acad Med Singap. 2009 Jan;38(1):22-7
pubmed: 19221667
Physiol Behav. 1983 Feb;30(2):185-92
pubmed: 6844432
Obes Surg. 2009 Oct;19(10):1447-55
pubmed: 19655209
Biomed Res Int. 2019 Mar 5;2019:8073057
pubmed: 30949511
Nutrients. 2020 Mar 01;12(3):
pubmed: 32121549
Am J Clin Nutr. 2007 Feb;85(2):346-54
pubmed: 17284728
Sci Rep. 2020 Jul 2;10(1):10873
pubmed: 32616827

Auteurs

Syed Mohammed Basheeruddin Asdaq (S)

Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, 13713 Riyadh, Saudi Arabia.

Shrey Tambe (S)

Department of Pharmacology, Krupanidhi College of Pharmacy, Bangalore 560035, India.

Yahya Mohzari (Y)

Clinical Pharmacy Department, King Saud Medical City, Riyadh 12746, Saudi Arabia.

Ahmed Alrashed (A)

Pharmaceutical Services Administration, Inpatient Department, Main Hospital, KFMC, Riyadh 11564, Saudi Arabia.

Hamdan Najib Alajami (H)

Pharmaceutical Services Administration, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.

Awad Othman Aljohani (A)

Pharmaceutical Services Administration, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.

Abdullah Ali Al Mushtawi (A)

Pharmaceutical Services Administration, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.

Majed Sultan Alenazy (M)

Pharmaceutical Services Administration, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.

Rakan Fahad Alamer (R)

Pharmaceutical Services Administration, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.

Abdulmajead Khalid Alanazi (A)

Pharmaceutical Services Administration, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.

Syed Imam Rabbani (S)

Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.

Classifications MeSH